Literature DB >> 31985200

Extended Recognition of the Histone H3 Tail by Histone Demethylase KDM5A.

Nektaria Petronikolou1, James E Longbotham1, Danica Galonić Fujimori1,2.   

Abstract

Human lysine demethylase KDM5A is a chromatin-modifying enzyme associated with transcriptional regulation, because of its ability to catalyze removal of methyl groups from methylated lysine 4 of histone H3 (H3K4me3). Amplification of KDM5A is observed in many cancers, including breast cancer, prostate cancer, hepatocellular carcinoma, lung cancer, and gastric cancer. In this study, we employed alanine scanning mutagenesis to investigate substrate recognition of KDM5A and identify the H3 tail residues necessary for KDM5A-catalyzed demethylation. Our data show that the H3Q5 residue is critical for substrate recognition by KDM5A. Our data also reveal that the protein-protein interactions between KDM5A and the histone H3 tail extend beyond the amino acids proximal to the substrate mark. Specifically, demethylation activity assays show that deletion or mutation of residues at positions 14-18 on the H3 tail results in an 8-fold increase in the KMapp, compared to wild-type 18mer peptide, suggesting that this distal epitope is important in histone engagement. Finally, we demonstrate that post-translational modifications on this distal epitope can modulate KDM5A-dependent demethylation. Our findings provide insights into H3K4-specific recognition by KDM5A, as well as how chromatin context can regulate KDM5A activity and H3K4 methylation status.

Entities:  

Year:  2020        PMID: 31985200      PMCID: PMC7207076          DOI: 10.1021/acs.biochem.9b01036

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  20 in total

1.  RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3.

Authors:  Jesper Christensen; Karl Agger; Paul A C Cloos; Diego Pasini; Simon Rose; Lau Sennels; Juri Rappsilber; Klaus H Hansen; Anna Elisabetta Salcini; Kristian Helin
Journal:  Cell       Date:  2007-02-22       Impact factor: 41.582

2.  From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors.

Authors:  Jun Liang; Sharada Labadie; Birong Zhang; Daniel F Ortwine; Snahel Patel; Maia Vinogradova; James R Kiefer; Till Mauer; Victor S Gehling; Jean-Christophe Harmange; Richard Cummings; Tommy Lai; Jiangpeng Liao; Xiaoping Zheng; Yichin Liu; Amy Gustafson; Erica Van der Porten; Weifeng Mao; Bianca M Liederer; Gauri Deshmukh; Le An; Yingqing Ran; Marie Classon; Patrick Trojer; Peter S Dragovich; Lesley Murray
Journal:  Bioorg Med Chem Lett       Date:  2017-05-05       Impact factor: 2.823

3.  Structure of the Arabidopsis JMJ14-H3K4me3 Complex Provides Insight into the Substrate Specificity of KDM5 Subfamily Histone Demethylases.

Authors:  Zhenlin Yang; Qi Qiu; Wei Chen; Bei Jia; Xiaomei Chen; Hongmiao Hu; Kaixuan He; Xian Deng; Sisi Li; W Andy Tao; Xiaofeng Cao; Jiamu Du
Journal:  Plant Cell       Date:  2017-12-12       Impact factor: 11.277

4.  The retinoblastoma binding protein RBP2 is an H3K4 demethylase.

Authors:  Robert J Klose; Qin Yan; Zuzana Tothova; Kenichi Yamane; Hediye Erdjument-Bromage; Paul Tempst; D Gary Gilliland; Yi Zhang; William G Kaelin
Journal:  Cell       Date:  2007-02-22       Impact factor: 41.582

5.  Expression patterns and post-translational modifications associated with mammalian histone H3 variants.

Authors:  Sandra B Hake; Benjamin A Garcia; Elizabeth M Duncan; Monika Kauer; Graham Dellaire; Jeffrey Shabanowitz; David P Bazett-Jones; C David Allis; Donald F Hunt
Journal:  J Biol Chem       Date:  2005-11-02       Impact factor: 5.157

6.  An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells.

Authors:  Maia Vinogradova; Victor S Gehling; Amy Gustafson; Shilpi Arora; Charles A Tindell; Catherine Wilson; Kaylyn E Williamson; Gulfem D Guler; Pranoti Gangurde; Wanda Manieri; Jennifer Busby; E Megan Flynn; Fei Lan; Hyo-Jin Kim; Shobu Odate; Andrea G Cochran; Yichin Liu; Matthew Wongchenko; Yibin Yang; Tommy K Cheung; Tobias M Maile; Ted Lau; Michael Costa; Ganapati V Hegde; Erica Jackson; Robert Pitti; David Arnott; Christopher Bailey; Steve Bellon; Richard T Cummings; Brian K Albrecht; Jean-Christophe Harmange; James R Kiefer; Patrick Trojer; Marie Classon
Journal:  Nat Chem Biol       Date:  2016-05-23       Impact factor: 15.040

7.  Systems Level Analysis of Histone H3 Post-translational Modifications (PTMs) Reveals Features of PTM Crosstalk in Chromatin Regulation.

Authors:  Veit Schwämmle; Simone Sidoli; Chrystian Ruminowicz; Xudong Wu; Chung-Fan Lee; Kristian Helin; Ole N Jensen
Journal:  Mol Cell Proteomics       Date:  2016-06-14       Impact factor: 5.911

8.  Histone H3 binding to the PHD1 domain of histone demethylase KDM5A enables active site remodeling.

Authors:  James E Longbotham; Cynthia M Chio; Venkatasubramanian Dharmarajan; Michael J Trnka; Idelisse Ortiz Torres; Devrishi Goswami; Karen Ruiz; Alma L Burlingame; Patrick R Griffin; Danica Galonić Fujimori
Journal:  Nat Commun       Date:  2019-01-09       Impact factor: 14.919

9.  Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger.

Authors:  Gang G Wang; Jikui Song; Zhanxin Wang; Holger L Dormann; Fabio Casadio; Haitao Li; Jun-Li Luo; Dinshaw J Patel; C David Allis
Journal:  Nature       Date:  2009-06-11       Impact factor: 49.962

10.  8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors.

Authors:  Vassilios Bavetsias; Rachel M Lanigan; Gian Filippo Ruda; Butrus Atrash; Mark G McLaughlin; Anthony Tumber; N Yi Mok; Yann-Vaï Le Bihan; Sally Dempster; Katherine J Boxall; Fiona Jeganathan; Stephanie B Hatch; Pavel Savitsky; Srikannathasan Velupillai; Tobias Krojer; Katherine S England; Jimmy Sejberg; Ching Thai; Adam Donovan; Akos Pal; Giuseppe Scozzafava; James M Bennett; Akane Kawamura; Catrine Johansson; Aleksandra Szykowska; Carina Gileadi; Nicola A Burgess-Brown; Frank von Delft; Udo Oppermann; Zoe Walters; Janet Shipley; Florence I Raynaud; Susan M Westaway; Rab K Prinjha; Oleg Fedorov; Rosemary Burke; Christopher J Schofield; Isaac M Westwood; Chas Bountra; Susanne Müller; Rob L M van Montfort; Paul E Brennan; Julian Blagg
Journal:  J Med Chem       Date:  2016-01-07       Impact factor: 7.446

View more
  6 in total

1.  Lysine demethylase 5A promotes prostate adenocarcinoma progression by suppressing microRNA-330-3p expression and activating the COPB2/PI3K/AKT axis in an ETS1-dependent manner.

Authors:  Yuanyuan Mi; Lifeng Zhang; Chuanyu Sun; Yanyan Feng; Jian Sun; Jun Wang; Dongjie Yang; Xiaowei Qi; Hongyuan Wan; Guowei Xia; Sheng Wu; Lijie Zhu
Journal:  J Cell Commun Signal       Date:  2022-05-18       Impact factor: 5.782

2.  Exploring the Ligand Preferences of the PHD1 Domain of Histone Demethylase KDM5A Reveals Tolerance for Modifications of the Q5 Residue of Histone 3.

Authors:  Sarah E Anderson; James E Longbotham; Patrick T O'Kane; Fatima S Ugur; Danica Galonić Fujimori; Milan Mrksich
Journal:  ACS Chem Biol       Date:  2020-12-14       Impact factor: 5.100

3.  Evaluation of Jumonji C lysine demethylase substrate preference to guide identification of in vitro substrates.

Authors:  Matthew Hoekstra; Anand Chopra; William G Willmore; Kyle K Biggar
Journal:  STAR Protoc       Date:  2022-03-30

4.  Histone demethylase KDM5A regulates the functions of human periodontal ligament stem cells during periodontitis via the miR-495-3p/HOXC8 axis.

Authors:  Fang Niu; Jing Xu; Yujuan Yan
Journal:  Regen Ther       Date:  2022-04-22       Impact factor: 3.651

5.  Recognition of Histone H3 Methylation States by the PHD1 Domain of Histone Demethylase KDM5A.

Authors:  James E Longbotham; Mark J S Kelly; Danica Galonić Fujimori
Journal:  ACS Chem Biol       Date:  2021-02-23       Impact factor: 4.634

6.  ELK4 promotes the development of gastric cancer by inducing M2 polarization of macrophages through regulation of the KDM5A-PJA2-KSR1 axis.

Authors:  Lei Zheng; Hongmei Xu; Ya Di; Lanlan Chen; Jiao Liu; Liying Kang; Liming Gao
Journal:  J Transl Med       Date:  2021-08-09       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.